GDC-0339 - CAS 1428569-85-0

GDC-0339 is discovered as a potential treatment of multiple myeloma. GDC-0339 is an orally bioavailable and well-tolerated inhibitor of the pan-Pim kinase (Kis: 0.03 nM, 0.1 nM, and 0.02 nM for Pim1, Pim2, and Pim3, respectively) .

Pim

Chromatin/Epigenetic, JAK/STAT signaling

1428484

C20H22F3N7OS

465.5

Cn1ncc(NC(=O)c2nc(sc2N)-c2c(F)cccc2F)c1N1CC[C@@H](N)[C@H](F)CC1

-20°C

Ice Packs

Small Compound